Table of Contents

company-logo

Biophytis S.A., a clinical-stage biotechnology company, focuses on the development of therapeutics that slow the degenerative processes and improve functional outcomes for patients suffering from age-related diseases. Its therapeutics focuses on targeting and activating key biological resilience pathways that could protect against and counteract the effects of the multiple biological and environmental stresses that lead to age-related diseases. The company's lead drug candidate is Sarconeos (BIO101), an orally administered small molecule in development for the treatment of neuromuscular diseases, including sarcopenia and Duchenne muscular dystrophy (DMD), as well as in Phase 2/3 clinical study for the treatment of severe respiratory failure in patients suffering from COVID-19. It also develops Macuneos (BIO201), an orally administered small molecule for the treatment of retinal diseases, including dry age-related macular degeneration (AMD) and Stargardt disease. Biophytis SA has a collaboration agreement with AFM-Telethon for the development of its Sarconeos (BIO101) for the treatment of DMD. The company was incorporated in 2006 and is headquartered in Paris, France.

Biophytis Dividend Announcement

• Biophytis does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Biophytis dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Biophytis Dividend History

Biophytis Dividend Yield

Biophytis current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Biophytis stock? Use our calculator to estimate your expected dividend yield:

Biophytis Financial Ratios

P/E ratio-1.20
PEG ratio-0.01
P/B ratio-5.27
ROE472.75%
Payout ratio0.00%
Current ratio0.72
Quick ratio0.72
Cash Ratio0.45

Biophytis Dividend FAQ

Does Biophytis stock pay dividends?
Biophytis does not currently pay dividends to its shareholders.
Has Biophytis ever paid a dividend?
No, Biophytis has no a history of paying dividends to its shareholders. Biophytis is not known for its dividend payments.
Why doesn't Biophytis pay dividends?
There are several potential reasons why Biophytis would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Biophytis ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Biophytis has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Biophytis a dividend aristocrat?
Biophytis is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Biophytis a dividend king?
Biophytis is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Biophytis a dividend stock?
No, Biophytis is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Biophytis stocks?
To buy Biophytis you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Biophytis stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.